Steris | STE - Gross Profit On Sales

Stock Price
247.36
Daily Change
3.55 1.46%
Monthly
-4.57%
Yearly
10.81%
Q1 Forecast
254.51

Steris reported $655.5M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
3M USD 2.06B 667M Dec/2025
Avanos Medical USD 86M 6.1M Sep/2025
Baxter International USD 950M 194M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
CONMED USD 218.29M 52.17M Dec/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
Dexcom USD 688.8M 99.8M Jun/2025
Ecolab USD 1.87B 63.5M Sep/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Fortive USD 708.9M 59.7M Dec/2025
Getinge SEK 5.05B 1.5B Dec/2024
Globus Medical USD 486.67M 725.06M Sep/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
J&J USD 16.6B 118M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
Olympus JPY 161.3B 26.17B Sep/2025
Owens Minor USD 526.01M 53.75M Mar/2025
ResMed USD 878.72M 57.9M Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Tandem Diabetes Care USD 134.29M 8.44M Sep/2025
Teleflex USD 451.64M 20.56M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025